Add to ORKGPrimary cardiac tumors are rare with an incidence ranging from 0.001% to 0.03% in autopsy series. The prognosis of cardiac sarcomas remains poor because it proliferates rapidly, and distant metastases are often found at diagnosis. We present a case of liposarcoma in the atrium of the heart as case report and same time ,we do a literature review about it. Case Report: We present the case of a young 30 years old female with a significant tumor of cardiac liposarcoma, with chief complaint of dyspnea, tachycardia and heart failure even angina pectoris. Conclusion: The diagnostician’s differential diagnosis must be broad when encountering common chief complaints, such as tachycardia, heart failure and angina pectoris
Background Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and aro...
Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months. Data suggest that an...
Primary cardiac tumors are rare in all ages. Their reported prevalence ranges from 0.001 to 0.03 per...
Background: Malignant cardiac tumors are rare and have an extremely poor prognosis even when complet...
Background: Malignant cardiac tumors are rare and have an extremely poor prognosis even when complet...
Introduction: Primary cardiac sarcoma (PCS) has a poor prognosis compared to other sarcomas due to l...
Primary cardiac tumors are rare and are usually diagnosed at an advanced stage due to nonspecific sy...
International audienceINTRODUCTION: Primary cardiac sarcomas (PCS) are rare tumours of dismal progno...
Background: Malignant cardiac tumors are rare and have an extremely poor prognosis even when complet...
Primary cardiac tumors are rare with an incidence of 0.0017 to 0.0019%. Approximately 25% of these t...
Introduction: Primary tumors of the heart are exceedingly rare, accounting for less than 5% of all c...
Inrtoduction: Cardiac tumors are exceedingly rare. Majority of tumors are metastatic secondaries ra...
• Primary malignant cardiac tumors (PMCTs) represent about 10% of primary cardiactumors and survival...
Background Primary tumors of the heart represent an exceedingly rare entity in cardiac surgery and ...
Background Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and aro...
Background Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and aro...
Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months. Data suggest that an...
Primary cardiac tumors are rare in all ages. Their reported prevalence ranges from 0.001 to 0.03 per...
Background: Malignant cardiac tumors are rare and have an extremely poor prognosis even when complet...
Background: Malignant cardiac tumors are rare and have an extremely poor prognosis even when complet...
Introduction: Primary cardiac sarcoma (PCS) has a poor prognosis compared to other sarcomas due to l...
Primary cardiac tumors are rare and are usually diagnosed at an advanced stage due to nonspecific sy...
International audienceINTRODUCTION: Primary cardiac sarcomas (PCS) are rare tumours of dismal progno...
Background: Malignant cardiac tumors are rare and have an extremely poor prognosis even when complet...
Primary cardiac tumors are rare with an incidence of 0.0017 to 0.0019%. Approximately 25% of these t...
Introduction: Primary tumors of the heart are exceedingly rare, accounting for less than 5% of all c...
Inrtoduction: Cardiac tumors are exceedingly rare. Majority of tumors are metastatic secondaries ra...
• Primary malignant cardiac tumors (PMCTs) represent about 10% of primary cardiactumors and survival...
Background Primary tumors of the heart represent an exceedingly rare entity in cardiac surgery and ...
Background Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and aro...
Background Primary cardiac tumors are extremely rare. Most primary cardiac tumors are benign and aro...
Primary cardiac sarcomas are rare tumors with a median survival of 6-12 months. Data suggest that an...
Primary cardiac tumors are rare in all ages. Their reported prevalence ranges from 0.001 to 0.03 per...